Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings

N/AActive Not RecruitingNCT06963255

Hospices Civils de Lyon40 enrolled

Overview

This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic environment in either of the two centers between January 2024 and January 2025 will be included. Imaging exams and clinical follow-up data will be analyzed. Reinterventions and causes of death will be recorded. All imaging required for the 6-month follow-up is routinely performed as part of standard care. No modification of patient management is planned.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Revascularization in a Septic or Potentially Septic Environment

Interventions

arterial revascularizationPROCEDURE

arterial revascularization

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patient * Requiring revascularization in a septic or high-risk septic environment * With an estimated life expectancy of 12 months or more based on medical and surgical assessment * Informed about the study Exclusion Criteria: * Pregnant women * Individuals for whom regular medical follow-up cannot be ensured

Locations (2)

CHU de Bordeaux

Bordeaux, France

HCL hopital Louis Pradel

Bron, France

Outcomes

Primary Outcomes

To evaluate the 6-month primary patency of revascularizations using arterial allografts preserved at +2 to +8°C

Evaluation of the 6-month primary patency of the revascularization, defined as the percentage of patients with a patent bypass without reintervention or \>50% stenosis, confirmed by a morphological imaging exam (Doppler ultrasound or CT angiography) performed at 6 months

Time frame: 6 month